151 related articles for article (PubMed ID: 1305422)
21. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
[TBL] [Abstract][Full Text] [Related]
22. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.
Alonso DF; Gabri MR; Guthmann MD; Fainboim L; Gomez DE
Int J Oncol; 1999 Jul; 15(1):59-66. PubMed ID: 10375594
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
24. Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.
Harada Y; Sakatsume M; Taniguchi M
Jpn J Cancer Res; 1990 Apr; 81(4):383-7. PubMed ID: 2142151
[TBL] [Abstract][Full Text] [Related]
25. Preparation and specificity of 11 monoclonal antibodies to GM1 ganglioside.
Mahadik SP; Laev H; Rapport MM
J Neurochem; 1986 Oct; 47(4):1172-5. PubMed ID: 2427655
[TBL] [Abstract][Full Text] [Related]
26. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
[TBL] [Abstract][Full Text] [Related]
27. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
Watarai S; Kiura K; Shigeto R; Shibayama T; Kimura I; Yasuda T
J Biochem; 1994 Nov; 116(5):948-54. PubMed ID: 7896755
[TBL] [Abstract][Full Text] [Related]
28. Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
Iznaga N; Carr A; Fernández LE; Solozabal J; Núñez G; Perdomo Y; Morales A
J Clin Lab Immunol; 1996; 48(2):75-85. PubMed ID: 16296265
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N
J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075
[TBL] [Abstract][Full Text] [Related]
30. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
[TBL] [Abstract][Full Text] [Related]
31. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
32. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
[TBL] [Abstract][Full Text] [Related]
33. Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.
Piperno GM; López-Requena A; Predonzani A; Dorvignit D; Labrada M; Zentilin L; Burrone OR; Cesco-Gaspere M
Gene Ther; 2015 Dec; 22(12):960-7. PubMed ID: 26181624
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice.
Van Snick JL; Coulie P
J Exp Med; 1982 Jan; 155(1):219-30. PubMed ID: 6976413
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody MACG1 distinguishes between different molecular species of the ganglioside GM3.
Schriever F; Dennis RD; Pallmann B; Riethmüller G; Johnson JP
Hybridoma; 1989 Apr; 8(2):153-9. PubMed ID: 2714813
[TBL] [Abstract][Full Text] [Related]
36. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT
Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557
[TBL] [Abstract][Full Text] [Related]
37. Immunogenetic analysis of variable regions encoding AB1 and gamma-type AB2 antibodies from the NeuGc-containing ganglioside family.
Perez A; Lombardero J; Mateo C; Mustelier G; Alfonso M; Vazquez AM; Perez R
Hybridoma; 2001 Aug; 20(4):211-21. PubMed ID: 11604106
[TBL] [Abstract][Full Text] [Related]
38. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
39. [Autoantibodies to ganglioside GM3 and serotonin in blood serum in atherosclerosis].
Golovanova NK; Basharova LA; Kononova OI; Kozlov SG; Prokazova NV; Liakishev AA
Biokhimiia; 1995 May; 60(5):709-17. PubMed ID: 7662797
[TBL] [Abstract][Full Text] [Related]
40. Improvement of the immune efficacy of carbohydrate vaccines by chemical modification on the GM3 antigen.
Zheng XJ; Yang F; Zheng M; Huo CX; Zhang Y; Ye XS
Org Biomol Chem; 2015 Jun; 13(22):6399-406. PubMed ID: 25982227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
